Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

June 24, 2022

Study Completion Date

June 24, 2022

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

Lemzoparlimab

Intravenous (IV) infusion

DRUG

Dexamethasone

Oral tablet or IV infusion/injection

DRUG

Carfilzomib

IV infusion

DRUG

Pomalidomide

Oral capsule

BIOLOGICAL

Daratumumab

Subcutaneous (SC) injection

Trial Locations (32)

3004

Alfred Health /ID# 229347, Melbourne

5011

The Queen Elizabeth Hospital /ID# 229345, Woodville South

14004

Hospital Universitario Reina Sofia /ID# 229388, Córdoba

15706

Hospital Clínico Universitario de Santiago-CHUS /ID# 229356, Santiago de Compostela

22763

Asklepios Klinik Altona /ID# 229143, Hamburg

22908

University of Virginia /ID# 229396, Charlottesville

27710

Duke University Hospital /ID# 229564, Durham

28041

Hospital Universitario 12 de Octubre /ID# 229355, Madrid

39008

Hospital Unversitario Marques de Valdecilla /ID# 229354, Santander

40207

Norton Cancer Institute - St Matthews /ID# 229319, Louisville

44000

CHU de Nantes, Hotel Dieu -HME /ID# 228559, Nantes

48109

University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 229309, Ann Arbor

48202

Henry Ford Health System /ID# 230341, Detroit

69495

HCL - Hôpital Lyon Sud /ID# 229834, Pierre-Bénite

70112

Tulane Cancer Center Clinic /ID# 229832, New Orleans

86000

CHU Poitiers - La milétrie /ID# 229833, Poitiers

91120

Hadassah Medical Center-Hebrew University /ID# 229477, Jerusalem

94000

Hopital Henri Mondor /ID# 228562, Créteil

3109601

Rambam Health Care Campus /ID# 229485, Haifa

4428164

Meir Medical Center /ID# 229480, Kfar Saba

4941492

Rabin Medical Center /ID# 229488, Petah Tikva

5265601

The Chaim Sheba Medical Center /ID# 229483, Ramat Gan

6423906

Tel Aviv Sourasky Medical Center /ID# 229478, Tel Aviv

33136-1002

Sylvester Comprehensive Cancer Center /ID# 228817, Miami

33612-9416

Moffitt Cancer Center /ID# 229939, Tampa

08901

Rutgers Cancer Institute of New Jersey /ID# 230174, New Brunswick

10032-3729

Columbia University Medical Center /ID# 229971, New York

27157-0001

Wake Forest Baptist Health /ID# 229996, Winston-Salem

19104-5127

Perelman Center for Advanced Medicine - /ID# 228693, Philadelphia

602-8566

University Hospital Kyoto Prefectural University of Medicine /ID# 241833, Kyoto

08003

Hospital Parc de Salut del Mar /ID# 229371, Barcelona

08041

Hospital Santa Creu i Sant Pau /ID# 229369, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY